| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Orenstein Daniel H. serves as a General Counsel at HCAT. Across recent SEC filings that breaks down to 0 buys and 40 sells. Those positions are worth an estimated $226K at current prices.
Historically, Orenstein Daniel H.'s trades have earned a strong insider score of 84/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +59.2%.
The biggest single holding is HCAT (~$226K) as General Counsel. The recent filings there lean toward selling, a net 120,389 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | HCAT Health Catalyst, Inc. | General Counsel | Sell | 2,838 | $11.27 | $31,978.02 | -2.8% | -3.0% | +6.5% | |
| Jun 6, 2022 | HCAT Health Catalyst, Inc. | General Counsel | Sell | 2,838 | $14.85 | $42,139.76 | -2.7% | -23.0% | -15.6% | |
| Mar 3, 2022 | HCAT Health Catalyst, Inc. | General Counsel | Sell | 4,112 | $26.82 | $110,271.09 | -3.8% | -47.4% | -47.0% | |
| Dec 6, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 7,133 | $39.93 | $284,846.64 | -3.3% | -37.7% | -74.8% | |
| Nov 1, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 2,500 | $53.58 | $133,958.23 | -1.6% | -44.7% | -83.3% | |
| Oct 1, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 2,500 | $49.21 | $123,014.00 | -3.2% | -18.1% | -80.4% | |
| Sep 3, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 3,852 | $54.32 | $209,243.72 | -4.9% | -21.4% | -78.9% | |
| Aug 2, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 2,500 | $58.04 | $145,108.25 | -3.1% | -6.8% | -69.6% | |
| Jul 1, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 2,500 | $55.98 | $139,957.16 | -1.6% | -11.3% | -72.7% | |
| Jun 3, 2021 | HCAT Health Catalyst, Inc. | General Counsel | Sale+OE | 3,872 | $52.81 | $204,469.87 | -4.7% | +2.3% | -71.8% |